Compare MSA & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSA | LNTH |
|---|---|---|
| Founded | 1914 | 1956 |
| Country | United States | United States |
| Employees | 5300 | N/A |
| Industry | Industrial Specialties | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 6.5B |
| IPO Year | N/A | 2014 |
| Metric | MSA | LNTH |
|---|---|---|
| Price | $171.48 | $109.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $197.40 | $87.00 |
| AVG Volume (30 Days) | 326.1K | ★ 842.5K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.29% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.80 |
| Revenue | N/A | ★ $343,374,000.00 |
| Revenue This Year | $6.78 | N/A |
| Revenue Next Year | $5.00 | $14.19 |
| P/E Ratio | ★ $28.18 | $61.04 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $151.11 | $47.27 |
| 52 Week High | $208.92 | $111.86 |
| Indicator | MSA | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 58.12 | 68.13 |
| Support Level | $164.63 | $95.00 |
| Resistance Level | $175.95 | N/A |
| Average True Range (ATR) | 3.98 | 3.08 |
| MACD | 1.36 | 0.05 |
| Stochastic Oscillator | 77.99 | 80.78 |
MSA Safety Inc makes safety products that are used to protect workers in the oil and gas and mining industries. The company's product offerings include breathing apparatuses, fall protection, portable gas detection systems, industrial head protection, fire and rescue helmets, and fixed gas and flame detection systems, among others. The end markets for its products include the fire service, contractor, industrial, mining, oil and gas, and utilities industries. The company has organized its business into four geographical operating segments that are aggregated into two reportable segments: Americas and International. The majority of its revenue is generated from the Americas segment, which is comprised of the company's operations in Northern North America and Latin America geographies.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.